Cardiovascular effects of melanocortins

European Journal of Pharmacology

Volumn 660, Issue 1, 2011, Pages 43-52

  Humphreys, Michael H ^a   Ni, Xi Ping ^a   Pearce, David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

melanocyte stimulating hormone; Blood pressure; Insulin resistance; Noradrenergic activity; Salt sensitive hypertension

Indexed keywords

ALPHA INTERMEDIN; AMILORIDE; BROMOCRIPTINE; GAMMA INTERMEDIN; GAMMA2 INTERMEDIN; HYDRALAZINE; INSULIN; MELANOCORTIN; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN 2 RECEPTOR; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 5 RECEPTOR; NORADRENALIN; PHENTOLAMINE; PROLACTIN; PROOPIOMELANOCORTIN; PROPROTEIN CONVERTASE 1; PROPROTEIN CONVERTASE 2; SODIUM; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE REGULATION; CONTINUOUS INFUSION; DRUG RECEPTOR BINDING; GENE DELETION; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HIGH SODIUM INTAKE; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; NATRIURESIS; NONHUMAN; NORADRENALIN BLOOD LEVEL; NORADRENERGIC SYSTEM; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SODIUM URINE LEVEL;

ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; GAMMA-MSH; GLUCOSE; HUMANS; MELANOCORTINS; SIGNAL TRANSDUCTION;

EID: 79955937535     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.10.102     Document Type: Review

References (95)

1. Adams, J.M., Madden, C.J., Sved, A.F., Stocker, S.D., 2007. Increased dietary salt enhances sympathoexcitatory and sympathoinhibitory responses from the rostral ventrolateral medulla. Hypertension 50, 354-359. (Pubitemid 47205785)
2. Allen, R.G., Peng, B., Pellegrino, M.J., Miller, E.D., Grandy, D.K., Lundblad, J.R., Washburn, C.L., Pintar, J.E., 2001. Altered processing of pro-orphanin FQ/nociceptin and proopiomelanocortin- derived peptides in the brains of mice expressing defective prohormone convertase 2. J. Neurosci. 21, 5864-5870. (Pubitemid 32737719)
3. Autelitano, D.J., Lundblad, J.R., Blum, M., Roberts, J.L., 1989. Hormonal regulation of POMC gene expression. Annu. Rev. Physiol. 51, 715-726.
4. Baum, M., 1987. Insulin stimulates volume absorption in the rabbit proximal convoluted tubule. J. Clin. Invest. 79, 1104-1109.
5. Bealer, S.L., Metcalf, C.S., 2005. Increased dietary sodium enhances activation of neurons in the medullary cardiovascular pathway during acute sodium loading in the rat. Auton. Neurosci. 117, 33-40.
6. Berman, Y., Mzhavia, N., Polonskaia, A., Furuta, M., Steiner, D.F., Pintar, J.E., Devi, L.A., 2000. Defective prodynorphin processing in mice lacking prohormone convertase PC2. J. Neurochem. 75, 1763-1770.
7. Butler, A.A., 2006. The melanocortin system and energy balance. Peptides 27, 281-290. (Pubitemid 43162900)
8. Butler, A.A., Kesterson, R.A., Khong, K., Cullen, M.J., Pelleymounter, M.A., Dekoning, J., Baetscher, M., Cone, R.D., 2000. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 141, 3518-3521. (Pubitemid 32269044)
9. Callahan, M.F., Kirby, R.F., Lymangrover, J.R., Johnson, A.K., Gruber, K.A., 1984. Cardiovascular mechanisms of gamma (gamma) 2-MSH. Clin. Exp. Hypertens. A 6, 1727-1730.
10. Carey, R.M., Van Loon, G.R., Baines, A.D., Kaiser, D.L., 1983. Suppression of basal and stimulated noradrenergic activities by the dopamine agonist bromocriptine in man. J. Clin. Endocrinol. Metab. 56, 595-602.
11. Carter, D.A., Pardy, K., Murphy, D., 1993. Regulation of vasopressin gene expression: changes in the level, but not the size, of vasopressin mRNA following endocrine manipulations. Cell. Mol. Neurobiol. 13, 87-95.
12. Chandramohan, G., Ni, X.P., Kalinyak, J.E., Humphreys, M.H., 2001. Dietary sodium modulates mRNA abundance of enzymes involved in pituitary processing of proopiomelanocortin. Pituitary 4, 231-237.
13. Chandramohan, G., Durham, N., Sinha, S., Norris, K., Vaziri, N.D., 2009. Role of gamma melanocyte-stimulating hormone-renal melanocortin 3 receptor system in blood pressure regulation in salt-resistant and salt-sensitive rats. Metabolism 58, 1424-1429.
14. Chen, W., Kelly, M.A., Opitz-Araya, X., Thomas, R.E., Low, M.J., Cone, R.D., 1997a. Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides. Cell 91, 789-798. (Pubitemid 28007735)
15. Chen, X.W., Ying,W.Z., Valentin, J.P., Ling, K.T., Lin, S.Y.,Wiedemann, E., Humphreys, M.H., 1997b. Mechanism of the natriuretic action of gamma-melanocyte-stimulating hormone. Am. J. Physiol. 272, R1946-R1953.
16. Chen, A.S., Marsh, D.J., Trumbauer, M.E., Frazier, E.G., Guan, X.M., Yu, H., Rosenblum, C.I., Vongs, A., Feng, Y., Cao, L., Metzger, J.M., Strack, A.M., Camacho, R.E., Mellin, T.N., Nunes, C.N., Min, W., Fisher, J., Gopal-Truter, S., MacIntyre, D.E., Chen, H.Y., Van der Ploeg, L.H., 2000. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat. Genet. 26, 97-102.
17. Day, R., Schafer, M.K., Watson, S.J., Chretien, M., Seidah, N.G., 1992. Distribution and regulation of the prohormone convertases PC1 and PC2 in the rat pituitary. Mol. Endocrinol. 6, 485-497.
18. De Wildt, D.J., Van der Ven, J.C., Van Bergen, P., De Lang, H., Versteeg, D.H., 1994. A hypotensive and bradycardic action of gamma 2-melanocyte- stimulating hormone (gamma 2-MSH) microinjected into the nucleus tractus solitarii of the rat. Naunyn Schmiedebergs Arch Pharmacol 349, 50-56. (Pubitemid 24045020)
19. DeFronzo, R.A., Cooke, C.R., Andres, R., Faloona, G.R., Davis, P.J., 1975. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J. Clin. Invest. 55, 845-855.
20. DiBona, G.F., Kopp, U.C., 1997. Neural control of renal function. Physiol. Rev. 77, 75-197.
21. Duplain, H., Burcelin, R., Sartori, C., Cook, S., Egli, M., Lepori, M., Vollenweider, P., Pedrazzini, T., Nicod, P., Thorens, B., Scherrer, U., 2001. Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 104, 342-345. (Pubitemid 32666958)
22. Ellacott, K.L., Cone, R.D., 2006. The role of the central melanocortin system in the regulation of food intake and energy homeostasis: lessons from mouse models. Philos. Trans. R. Soc. Lond. B Biol. Sci. 361, 1265-1274.
23. Ferrannini, E., Buzzigoli, G., Bonadonna, R., Giorico, M.A., Oleggini, M., Graziadei, L., Pedrinelli, R., Brandi, L., Bevilacqua, S., 1987. Insulin resistance in essential hypertension. N. Engl. J. Med. 317, 350-357.
24. Franchi, F., Lazzeri, C., Barletta, G., Ianni, L., Mannelli, M., 2001. Centrally mediated effects of bromocriptine on cardiac sympathovagal balance. Hypertension 38, 123-129. (Pubitemid 34224783)
25. Fujita, T., 2007. Insulin resistance and salt-sensitive hypertension in metabolic syndrome. Nephrol. Dial. Transplant. 22, 102-107.
26. Furuta,M., Yano, H., Zhou, A., Rouille, Y., Holst, J.J., Carroll, R., Ravazzola,M., Orci, L., Furuta, H., Steiner, D.F., 1997. Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2. Proc. Natl. Acad. Sci. USA 94, 6646-6651.
27. Furuta, M., Carroll, R., Martin, S., Swift, H.H., Ravazzola, M., Orci, L., Steiner, D.F., 1998. Incomplete processing of proinsulin to insulin accompanied by elevation of Des- 31,32 proinsulin intermediates in islets of mice lacking active PC2. J. Biol. Chem. 273, 3431-3437.
28. Furuta, M., Zhou, A., Webb, G., Carroll, R., Ravazzola, M., Orci, L., Steiner, D.F., 2001. Severe defect in proglucagon processing in islet A-cells of prohormone convertase 2 null mice. J. Biol. Chem. 276, 27197-27202.
29. Gaziano, J.M., Cincotta, A.H., O'Connor, C.M., Ezrokhi, M., Rutty, D., Ma, Z.J., Scranton, R.E., 2010. Randomized clinical trial of quick-release bromocriptine among patients with type 2 diabetes on overall safety and cardiovascular outcomes. Diab. Care 33, 1503-1508.
30. Getting, S.J., Lam, C.W., Chen, A.S., Grieco, P., Perretti, M., 2006. Melanocortin 3 receptors control crystal-induced inflammation. FASEB J. 20, 2234-2241. (Pubitemid 44953853)
31. Gruber, K.A., Callahan, M.F., 1989. ACTH-(4-10) through gamma-MSH: evidence for a new class of central autonomic nervous system-regulating peptides. Am. J. Physiol. 257, R681-R694.
32. Guyton, A.C., 1991. Blood pressure control-special role of the kidneys and body fluids. Science 252, 1813-1816. (Pubitemid 21917099)
33. Hao, J., Rabkin, S.W., 1996. Differences in pituitary expression of proopiomelanocortin in Dahl salt-resistant and salt-sensitive rats on a high salt diet. Can. J. Physiol. Pharmacol. 74, 657-662.
34. Hill, C., Dunbar, J.C., 2002. The effects of acute and chronic alpha melanocyte stimulating hormone (alphaMSH) on cardiovascular dynamics in conscious rats. Peptides 23, 1625-1630. (Pubitemid 35246282)
35. Holtzman, E.J., Braley, L.M., Williams, G.H., Hollenberg, N.K., 1988. Kinetics of sodium homeostasis in rats: rapid excretion and equilibration rates. Am. J. Physiol. 254, R1001-R1006.
36. Hruby, V.J., Cai, M., Cain, J.P., Mayorov, A.V., Dedek, M.M., Trivedi, D., 2007. Design, synthesis and biological evaluation of ligands selective for the melanocortin-3 receptor. Curr. Top. Med. Chem. 7, 1107-1119.
37. Huang, B.S., Leenen, F.H., 2002. Brain amiloride-sensitive Phe-Met-Arg-Phe-NH(2)- gated Na(+) channels and Na(+)-induced sympathoexcitation and hypertension. Hypertension 39, 557-561. (Pubitemid 34165182)
38. Humphreys, M.H., 2004. Gamma-MSH, sodium metabolism, and salt-sensitive hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286, R417-R430.
39. Humphreys, M.H., Friedler, R.M., Earley, L.E., 1970. Natriuresis produced by vasopressin or hemorrhage during water diuresis in the dog. Am. J. Physiol. 219, 658-665.
40. Hussain, T., Abdul-Wahab, R., Lokhandwala, M.F., 1997. Bromocriptine stimulates Na+, K(+)-ATPase in renal proximal tubules via the cAMP pathway. Eur. J. Pharmacol. 321, 259-263.
41. Huszar, D., Lynch, C.A., Fairchild-Huntress, V., Dunmore, J.H., Fang, Q., Berkemeier, L.R., Gu, W., Kesterson, R.A., Boston, B.A., Cone, R.D., Smith, F.J., Campfield, L.A., Burn, P., Lee, F., 1997. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88, 131-141. (Pubitemid 27180337)
42. Ibarra, F., Crambert, S., Eklof, A.C., Lundquist, A., Hansell, P., Holtback, U., 2005. Prolactin, a natriuretic hormone, interacting with the renal dopamine system. Kidney Int. 68, 1700-1707. (Pubitemid 43169914)
43. Isogai, O., Tsukamoto, K., Masubuchi, Y., Tomioka, S., Suzuki, T., Kawato, H., Yajima, Y., Kasamaki, Y., Ito, S., Kanmatsuse, K., 2005. High salt diet enhances cardiovascular responses from the nucleus tractus solitarius and ventrolateral medulla of Sprague-Dawley rats. Clin. Exp. Hypertens. 27, 33-44.
44. Johnston, C.I., 1985. Vasopressin in circulatory control and hypertension. J. Hypertens. 3, 557-569. (Pubitemid 16205132)
45. Kanayama, Y., Kohno, M., Takaori, K., Itoh, S., Yasunari, K., Takeda, T., 1987. Involvement of sympathetic nervous system inhibition in the hypotensive effect of bromocriptine in spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 14, 141-144.
46. Kok, P., Roelfsema, F., Frolich, M., van Pelt, J., Stokkel, M.P., Meinders, A.E., Pijl, H., 2006. Activation of dopamine D2 receptors simultaneously ameliorates various metabolic features of obese women. Am. J. Physiol. Endocrinol. Metab. 291, E1038-E1043.
47. Kunos, G., Li, S-J., Varga, K., Archer, P., Kesterson, R.A., Cone, R.D., Hruby, V.J., Sharma, S.D., 1997. Novel neural pathways of cardiovascular control by á- and γ-MSH. Fundam. Clin. Pharmacol. 11 (Suppl 1), 44s-483s.
48. Laakso, M., Edelman, S.V., Brechtel, G., Baron, A.D., 1990. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J. Clin. Invest. 85, 1844-1852.
49. Li, S.J., Varga, K., Archer, P., Hruby, V.J., Sharma, S.D., Kesterson, R.A., Cone, R.D., Kunos, G., 1996. Melanocortin antagonists define two distinct pathways of cardiovascular control by alpha- and gamma-melanocyte-stimulating hormones. J. Neurosci. 16, 5182-5188. (Pubitemid 26269676)
50. Lin, S.Y., Chaves, C., Wiedemann, E., Humphreys, M.H., 1987. A gamma-melanocyte stimulating hormone-like peptide causes reflex natriuresis after acute unilateral nephrectomy. Hypertension 10, 619-627. (Pubitemid 18065142)
51. Lingueglia, E., Champigny, G., Lazdunski, M., Barbry, P., 1995. Cloning of the amiloride-sensitive FMRFamide peptide-gated sodium channel. Nature 378, 730-733. (Pubitemid 26001946)
52. Lingueglia, E., Deval, E., Lazdunski, M., 2006. FMRFamide-gated sodium channel and ASIC channels: a new class of ionotropic receptors for FMRFamide and related peptides. Peptides 27, 1138-1152.
53. Luo, S., Liang, Y., Cincotta, A.H., 1999. Intracerebroventricular administration of bromocriptine ameliorates the insulin-resistant/glucose- intolerant state in hamsters. Neuroendocrinology 69, 160-166. (Pubitemid 29134491)
54. Lymangrover, J.R., Buckalew, V.M., Harris, J., Klein, M.C., Gruber, K.A., 1985. Gamma- 2MSH is natriuretic in the rat. Endocrinology 116, 1227-1229.
55. Mannelli, M., Delitala, G., De Feo, M.L., Maggi, M., Cuomo, S., Piazzini, M., Guazzelli, R., Serio, M., 1984. Effects of different dopaminergic antagonists on bromocriptine-induced inhibition of norepinephrine release. J. Clin. Endocrinol. Metab. 59, 74-78.
56. Matsumura, K., Tsuchihashi, T., Abe, I., Iida, M., 2002. Central alpha-melanocyte-stimulating hormone acts at melanocortin-4 receptor to activate sympathetic nervous system in conscious rabbits. Brain Res. 948, 145-148. (Pubitemid 35283772)
57. Mayan, H., Ling, K.T., Kalinyak, J.E., Sharma, A., Wiedemann, E., Humphreys, M.H., 1993. Modulation by dietary salt intake of pituitary proopiomelanocortin (POMC) messenger RNA (mRNA) abundance in normotensive and hypertensive rats. Hypertension 22, 417.
58. Mayan, H., Ling, K.T., Lee, E.Y., Wiedemann, E., Kalinyak, J.E., Humphreys, M.H., 1996. Dietary sodium intake modulates pituitary proopiomelanocortin mRNA abundance. Hypertension 28, 244-249. (Pubitemid 26322797)
59. Mayan, H., Ni, X.P., Almog, S., Humphreys, M.H., 2003. Suppression of gammamelanocyte- stimulating hormone secretion is accompanied by salt-sensitive hypertension in the rat. Hypertension 42, 962-967. (Pubitemid 37413738)
60. Muntzel, M.S., Morgan, D.A., Mark, A.L., Johnson, A.K., 1994. Intracerebroventricular insulin produces nonuniform regional increases in sympathetic nerve activity. Am. J. Physiol. 267, R1350-R1355.
61. Muntzel, M.S., Crespo, R., Joseph, T., Onwumere, O., 2007. Dietary salt loading exacerbates the increase in sympathetic nerve activity caused by intravenous insulin infusion in rats. Metabolism 56, 373-379. (Pubitemid 46209228)
62. Nagahama, S., Chen, Y.F., Oparil, S., 1984. Mechanism of the depressor effect of bromocriptine in the spontaneously hypertensive rat. J. Pharmacol. Exp. Ther. 228, 370-375.
63. Nagahama, S., Chen, Y.F., Oparil, S., 1985. Enhanced depressor effect of bromocriptine in the DOCA/NaCl hypertensive rat. Am. J. Physiol. 249, H64-H70.
64. Nakanishi, S., Inoue, A., Kita, T., Nakamura, M., Chang, A.C., Cohen, S.N., Numa, S., 1979. Nucleotide sequence of cloned cDNA for bovine corticotropin-beta-lipotropin precursor. Nature 278, 423-427. (Pubitemid 9130699)
65. Ni, X.P., Humphreys, M.H., 2007. Prevention of salt-induced hypertension by an analog of gamma-melanocyte-stimulating hormone in the rat. Am. J. Hypertens. 20, 862-865.
66. Ni, X.P., Humphreys, M.H., 2008. Abnormal glucose metabolism in hypertensive mice with genetically interrupted gamma-melanocyte stimulating hormone signaling fed a high-sodium diet. Am. J. Hypertens. 21, 1284-1287.
67. Ni, X.P., Kesterson, R.A., Sharma, S.D., Hruby, V.J., Cone, R.D.,Wiedemann, E., Humphreys, M.H., 1998. Prevention of reflex natriuresis after acute unilateral nephrectomy by melanocortin receptor antagonists. Am. J. Physiol. 274, R931-R938.
68. Ni, X.P., Pearce, D., Butler, A.A., Cone, R.D., Humphreys, M.H., 2003. Genetic disruption of gamma-melanocyte-stimulating hormone signaling leads to salt-sensitive hypertension in the mouse. J. Clin. Invest. 111, 1251-1258.
69. Ni, X.P., Bhargava, A., Pearce, D., Humphreys, M.H., 2006a. Modulation by dietary sodium intake of melanocortin 3 receptor mRNA and protein abundance in the rat kidney. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290, R560-R567.
70. Ni, X.P., Butler, A.A., Cone, R.D., Humphreys, M.H., 2006b. Central receptors mediating the cardiovascular actions of melanocyte stimulating hormones. J. Hypertens. 24, 2239-2246. (Pubitemid 44611033)
71. Ni, X.P., van Dijk, C., Pearce, D., Humphreys, M.H., 2009. Evidence for a noradrenergic mechanism causing hypertension and abnormal glucose metabolism in rats with relative deficiency of gamma-melanocyte-stimulating hormone. Exp. Physiol. 94, 867-876.
72. Nijsen, M.J., de Ruiter, G.J., Kasbergen, C.M., Hoogerhout, P., de Wildt, D.J., 2000. Relevance of the C-terminal Arg-Phe sequence in gamma(2)-melanocyte-stimulating hormone (gamma(2)-MSH) for inducing cardiovascular effects in conscious rats. Br. J. Pharmacol. 131, 1468-1474.
73. Nishimura, M., Ohtsuka, K., Takahashi, H., Yoshimura, M., 2000. Role of FMRFamide-activated brain sodium channel in salt-sensitive hypertension. Hypertension 35, 443-450. (Pubitemid 30054214)
74. Oguro, M., Takeda, K., Itoh, H., Takesako, T., Tanaka, M., Takenaka, K., Hirata, M., Nakata, T., Tanabe, S., Hayashi, J., et al., 1992. Role of sympathetic nerve inhibition in the vasodepressor effect of bromocriptine in normotensive and hypertensive rats. Jpn Circ. J. 56, 943-949.
75. Oyarce, A.M., Hand, T.A., Mains, R.E., Eipper, B.A., 1996. Dopaminergic regulation of secretory granule-associated proteins in rat intermediate pituitary. J. Neurochem. 67, 229-241. (Pubitemid 26185601)
76. Pijl, H., Ohashi, S., Matsuda, M., Miyazaki, Y., Mahankali, A., Kumar, V., Pipek, R., Iozzo, P., Lancaster, J.L., Cincotta, A.H., DeFronzo, R.A., 2000. Bromocriptine: a novel approach to the treatment of type 2 diabetes. Diab. Care 23, 1154-1161. (Pubitemid 30616805)
77. Price, D.A., Greenberg, M.J., 1977. Structure of a molluscan cardioexcitatory neuropeptide. Science 197, 670-671.
78. Racz, K., Kuchel, O., Buu, N.T., 1986. Bromocriptine decreases blood pressure of spontaneously hypertensive rats without affecting the adrenomedullary synthesis of catecholamines. J. Cardiovasc. Pharmacol. 8, 676-680.
79. Reaven, G.M., Lithell, H., Landsberg, L., 1996. Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. N. Engl. J. Med. 334, 374-381.
80. Reudelhuber, T.L., 2003. Salt-sensitive hypertension: if only it were as simple as rocket science. J. Clin. Invest. 111, 1115-1116.
81. Sagnella, G.A., Markandu, N.D., Singer, D.R., MacGregor, G.A., 1990. Kinetics of renal sodium excretion during changes in dietary sodium intake in man - an exponential process? Clin. Exp. Hypertens. A 12, 171-178.
82. Schioth, H.B., 2001. The physiological role of melanocortin receptors. Vitam. Horm. 63, 195-232.
83. Smith, A.I., Funder, J.W., 1988. Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues. Endocr. Rev. 9, 159-179.
84. Sowers, J.R., 1981. Dopaminergic control of circadian norepinephrine levels in patients with essential hypertension. J. Clin. Endocrinol. Metab. 53, 1133-1137.
85. Steinberg, H.O., Brechtel, G., Johnson, A., Fineberg, N., Baron, A.D., 1994. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J. Clin. Invest. 94, 1172-1179.
86. Stier Jr., C.T., Cowden, E.A., Allison, M.E., 1982. Effects of bromocriptine on single nephron and whole-kidney function in rats. J. Pharmacol. Exp. Ther. 220, 366-370.
87. Strauss, M., Lamdin, E., Smith, W., Bleifer, D., 1958. Surfeit and deficit of sodium. A kinetic concept of sodium excretion. Arch. Intern. Med. 102, 527-536.
88. Van Bergen, P., Janssen, P.M., Hoogerhout, P., De Wildt, D.J., Versteeg, D.H., 1995. Cardiovascular effects of gamma-MSH/ACTH-like peptides: structure-activity relationship. Eur. J. Pharmacol. 294, 795-803.
89. Van Bergen, P., Van Der Vaart, J.G., Kasbergen, C.M., Versteeg, D.H., De Wildt, D.J., 1996. Structure-activity analysis for the effects of gamma-MSH/ACTH-like peptides on cerebral hemodynamics in rats. Eur. J. Pharmacol. 318, 357-368.
90. Van Bergen, P., Kleijne, J.A., De Wildt, D.J., Versteeg, D.H., 1997. Different cardiovascular profiles of three melanocortins in conscious rats; evidence for antagonism between gamma 2-MSH and ACTH-(1-24). Br. J. Pharmacol. 120, 1561-1567.
91. van den Buuse, M., Lambrechts, A.C., 1989. Bromocriptine-induced decrease in blood pressure in conscious spontaneously hypertensive rats: evidence for a peripheral site of action. J. Pharm. Pharmacol. 41, 644-646.
92. Van Dijk, C., Ni, X.-P., Humphreys, M.H., 2006. Correction of blood pressure in hypertensive rats with γ-melanocyte stimulating hormone (γ-MSH) deficiency rapidly corrects altered glucose homeostasis (abstract) J. Am. Soc. Nephrol. 17, 212A.
93. Wikberg, J.E., Muceniece, R., Mandrika, I., Prusis, P., Lindblom, J., Post, C., Skottner, A., 2000. New aspects on the melanocortins and their receptors. Pharmacol. Res. 42, 393-420.
94. Zhou, A., Bloomquist, B.T., Mains, R.E., 1993. The prohormone convertases PC1 and PC2 mediate distinct endoproteolytic cleavages in a strict temporal order during proopiomelanocortin biosynthetic processing. J. Biol. Chem. 268, 1763-1769.
95. Zhou, A., Webb, G., Zhu, X., Steiner, D.F., 1999. Proteolytic processing in the secretory pathway. J. Biol. Chem. 274, 20745-20748.